Financial Gravity Companies’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Financial Gravity Companies’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$1K	Buy	+68	New	+$760	﹤0.01%	1342

Other funds holding OSIR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Financial Gravity Companies's OSIR Position: Q4 2018 in Review

Financial Gravity Companies opened a new position in Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2018: 68 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #1342 among its holdings.

46 funds tracked by Wall St. Rank hold OSIR as of Q4 2018.

Financial Gravity Companies held 68 shares of Osiris Therapeutics, Inc. Common Stock worth $1K as of Q4 2018.
Osiris Therapeutics, Inc. Common Stock was a new Financial Gravity Companies position in Q4 2018.
Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of Financial Gravity Companies's portfolio in Q4 2018, its #1342 holding.
46 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Financial Gravity Companies's 13F filing for Q4 2018, filed 4 Feb 2019.